Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, or stroke.

Slower heart rate recovery before PCI independently predicts periprocedural myocardial infarction and may improve cardiac risk assessment.

Tirzepatide was noninferior to dulaglutide for the primary endpoint of time to first occurrence of death from cardiovascular causes, myocardial infarction, or stroke. Topline data were announced from ...

Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban ...

Analysing the forces at work behind the obstructions that cause heart attacks is crucial for identifying patients at risk of these events, says a study published today in eLife. The findings suggest ...

Global and genetic analyses link low physical activity to rising heart disease mortality, while higher activity levels appear ...

One way of combating atherosclerosis is to reduce levels of “bad cholesterol” in the blood. Scientists at the Swedish medical university Karolinska Institutet have now identified the genes that bring ...

A septal infarct is an area of dead tissue in the septum of the heart, which is a wall of tissue dividing the two sides of the heart. It happens when there is a blockage or reduction in its blood ...